Summary Biomatlante SA (Biomatlante) operates as a biologics solutions provider that manufactures, develops, and commercializes synthetic bone graft technologies and synthetic biomaterials for bone regeneration.The company’s products include inserts, granules, sticks, wedges, syringes, putty, screw and membrane, among others.
Its products are used in stomatology, dental regenerative, sports surgery, spine surgery and orthopaedics.Biomatlante’s leverages Micro Macroporous Biphasic Calcium Phosphate (MBCP) technology for the development of products.
The company works in collaboration with universities and research centers such as National Institute of Health and Medical Research, French National Center for Scientific Research, and other national and international universities for the development of novel projects. Biomatlante is headquartered in Vigneux de Bretagne, France.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Biomatlante SA - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Our reports have been used by over 10K customers, including:
‘Amyotropic Lateral Sclerosis (ALS) - Epidemiology Forecast – 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Amyotropic Lateral Sclerosis (ALS) epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Geographies Covered • The...
‘Hepatitis C Virus (HCV) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted HCV epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. Hepatitis C Virus (HCV) Understanding Hepatitis...
Asthma - Epidemiology Forecast to 2029 Summary Asthma is a common respiratory condition that affects the lungs.The airways in the lungs narrow and well, causing obstruction to the airflow (CDC, 2013; NHS, 2018). For some people asthma is mild, but in severe cases, people can experience life-threatening...
‘Adrenoleukodystrophy (ALD) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Adrenoleukodystrophy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Adrenoleukodystrophy (ALD) Understanding Adrenoleukodystrophy...
‘Acute Respiratory Distress Syndrome (ARDS)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Acute Respiratory Distress Syndrome (ARDS) epidemiology in the United States, EU5 (Germany, France, Italy, and United Kingdom), and Japan. Geographies Covered •...
‘Corneal Endothelial Dystrophy (CED) – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Corneal Endothelial Dystrophy, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Corneal Endothelial Dystrophy Disease Understanding Corneal...
‘Alcoholic Hepatitis - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical, and forecasted Alcoholic Hepatitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United...
‘Obstructive Sleep Apnea - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical, and forecasted Obstructive Sleep Apnea epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The...
‘AL Amyloidosis – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the AL Amyloidosis, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. AL Amyloidosis Disease Understanding Amyloidosis refers to a group of...
‘Diabetic Retinopathy (DR) – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Diabetic Retinopathy, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Diabetic Retinopathy Disease Understanding Diabetic retinopathy...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.